Skip to main content
. 2015 Dec 31;30(4):494–501. doi: 10.3803/EnM.2015.30.4.494

Table 1. The Association between Preoperative NLR and PLR Values and the Clinicopathological Characteristics of Papillary Thyroid Cancer.

Characteristic Patients, n (%) NLR PLR
Median (IQR) P value Median (IQR) P value
Age, yr 0.001 <0.001
 <45 324 (30.4) 1.75 (1.03-2.31) 135.60 (91.00-163.06)
 ≥45 742 (69.6) 1.52 (1.16-2.00) 123.60 (99.32-151.42)
Tumor size, cm 0.522 0.021
 ≤1 774 (75.6) 1.59 (1.20-2.06) 124.41 (103.13-155.09)
 >1 292 (27.4) 1.53 (1.22-2.12) 129.17 (106.24-162.44)
T stage 0.370 0.801
 1/2 944 (88.6) 1.57 (1.21-2.08) 125.62 (104.05-156.11)
 3/4 122 (11.4) 1.63 (1.20-2.13) 127.70 (97.84-156.75)
LNM 0.634 0.765
 N0 432 (40.5) 1.57 (1.19-2.07) 125.59 (103.28-156.72)
 N1 634 (59.5) 1.68 (1.34-2.24) 132.10 (114.12-149.81)
Multifocality 0.483 0.526
 Negative 746 (70) 1.60 (1.23-2.11) 126.06 (105.58-156.75)
 Positive 320 (30) 1.53 (1.16-2.04) 126.50 (99.35-154.50)
Hashimoto's thyroiditis 0.005 0.039
 Negative 940 (88.2) 1.58 (1.21-2.11) 127.61 (104.89-157.38)
 Positive 126 (11.8) 1.52 (1.18-1.89) 119.48 (94.02-147.48)
ETE 0.185 0.805
 Negative 654 (61.4) 1.59 (1.20-2.08) 124.31 (103.27-157.95)
 Positive 412 (38.6) 1.57 (1.22-2.10) 128.09 (106.15-154.26)
Lateral LNM 0.101 0.316
 Negative 1,001 (93.9) 1.57 (1.19-2.07) 125.59 (103.28-156.72)
 Positive 65 (6.1) 1.68 (1.34-2.24) 132.10 (114.38-148.46)
LVI 0.155 0.400
 Negative 524/715 (73.3) 1.58 (1.21-2.04) 126.96 (103.58-157.59)
 Positive 191/715 (26.7) 1.52 (1.13-2.22) 130.18 (104.77-158.92)
BRAF V600E mutation 0.896 0.658
 Negative 383/1,003 (38.2) 1.58 (1.17-2.08) 125.96 (101.57-154.28)
 Positive 620/1,003 (61.8) 1.57 (1.23-2.10) 125.68 (103.93-156.72)

Statistical significance was tested by the Student t test.

NLR, neutrophil-to-lymphocyte count ratio; PLR, platelet-to-lymphocyte count ratio; IQR, interquartile range; LNM, lymph node metastasis; ETE, extrathyroidal extension; LVI, lymphovascular invasion.